AFT Pharmaceutical's multi-billion R&D opportunity
Welcome to HotCopper’s latest Watchlist, where we’ve been joined by AFT Pharmaceuticals (ASX:AFP) founder and chief executive Hartley Atkinson to discuss its expanding global reach and the @tentative” FDA approval the company has just hauled i...
Market Cap $62.68M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
| Tag | Subject | ||||||
|---|---|---|---|---|---|---|---|
| DXN | Ann: Becoming a substantial holder from MQG | 24/04/18 | 14 | 2.7K | |||
|
|||||||
| DXN | listened to the noise then read the prospectus | 18/04/18 | 2 | 823 | |||
|
|||||||
| DXN | Unprecedented level of demand | 18/04/18 | 2 | 1.1K | |||
|
|||||||
| DXN | Cnbc Interview | 17/04/18 | 2 | 1.4K | |||
|
|||||||
| DXN | Ann: Initial Director's Interest Notice | 16/04/18 | 0 | 119 | |||
|
|||||||
| DXN | Ann: Appointment of Director | 16/04/18 | 0 | 133 | |||
|
|||||||
| DXN | Ann: Capital Structure | 14/04/18 | 53 | 14K | |||
|
|||||||
| DXN | Ann: Notice of Initial Substantial Holder | 12/04/18 | 0 | 114 | |||
|
|||||||
See All Discussions
melua
ASX News